Viberzi and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Viberzi (eluxadoline), especially for people who are female, 50-59 old, also take Vitamin D3, and have Pain.

The phase IV clinical study analyzes which people have Weight increased when taking Viberzi. It is created by eHealthMe based on reports of 3,052 people who have side effects when taking Viberzi from the FDA, and is updated regularly.

What is Viberzi?

Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,959 conditions by eHealthMe. Check the latest studies of Weight increased.

On Aug, 09, 2026

3,052 people reported to have side effects when taking Viberzi.
Among them, 30 people (0.98%) have Weight increased.

Among these 30 people:

What is the gender of people who have Weight increased when taking Viberzi? *

female: 85.19 %
male: 14.81 %

What is the age of people who have Weight increased when taking Viberzi? *

What are other drugs people take besides Viberzi? *

Vitamin D3: 8 people, 26.67%
Hydroxyzine: 7 people, 23.33%
Lyrica: 7 people, 23.33%
Carafate: 6 people, 20.00%
Macrodantin: 6 people, 20.00%
Oxycodone: 5 people, 16.67%
Percocet: 5 people, 16.67%
Heparin: 5 people, 16.67%
Vraylar: 5 people, 16.67%
Oxycodone And Acetaminophen: 5 people, 16.67%

What are other side effects people have besides Weight increased? *

Joint Pain: 7 people, 23.33%
Diarrhea: 7 people, 23.33%
Fall: 7 people, 23.33%
Feeling Abnormal: 7 people, 23.33%
High Blood Pressure: 6 people, 20.00%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 16.67%
Neuralgia (pain in one or more nerves): 5 people, 16.67%
Neuropathy Peripheral (surface nerve damage): 5 people, 16.67%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 16.67%
Oedema Peripheral (superficial swelling): 5 people, 16.67%

What are the existing conditions these people have? *

Pain: 8 people, 26.67%
Irritable Bowel Syndrome: 7 people, 23.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 23.33%
Migraine (headache): 6 people, 20.00%
Immunodeficiency Common Variable: 5 people, 16.67%
Mood Swings (an extreme or rapid change in mood): 4 people, 13.33%
Nausea (feeling of having an urge to vomit): 4 people, 13.33%
Muscle Spasms (muscle contraction): 4 people, 13.33%
Stress And Anxiety: 4 people, 13.33%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Viberzi and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viberzi:

Viberzi (3,077 reports)

Weight increased treatments and more:

Weight increased (279,370 reports)

Browse all side effects of Viberzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,959 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eluxadoline (the active ingredients of Viberzi) and Viberzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.